NASDAQ:CTNM - Nasdaq - US21217B1008 - Common Stock - Currency: USD
2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|
Revenue | 50.00M | 0.00 | 0.00 | |||
Operating Expenses | 33.92M | 22.72M | 28.65M | |||
Research and Development | 27.60M | 16.89M | 22.36M | |||
Selling, General, and Administrative Expenses | 6.32M | 5.83M | 6.29M | |||
Operating Income | 16.08M | -22.72M | -28.65M | |||
Interest Income/Expense | 4.40M | 373.00K | -255.00K | |||
Other Income/Expense | 2.69M | -1.91M | -99.00K | |||
Income Before Taxes | 23.17M | -24.25M | -29.00M | |||
Income Tax | 450.00K | N/A | N/A | |||
Net Income | 22.72M | -24.25M | -29.00M | |||
EBITDA | 16.27M | -22.39M | -28.32M | |||
Per Share Data | ||||||
EPS Diluted Total Ops | 0.90 | -0.97 | -1.15 | |||
Statistics | ||||||
Profit Margin | 45.44% | N/A | N/A | |||
Operating Profit Margin | 32.15% | N/A | N/A |
All data in USD